What is he best known for?
The fields of study he is best known for:
His primary areas of study are Immunology, Virology, T cell, CD8 and Cytotoxic T cell.
His study involves Immune system, Recent Thymic Emigrant, Immunity, T-cell receptor excision circles and Ebola vaccine, a branch of Immunology.
His studies deal with areas such as Antibody and Immunization as well as Virology.
He combines subjects such as Chemokine and Antigen with his study of T cell.
Richard A. Koup has included themes like Epitope and Flow cytometry in his CD8 study.
In his study, which falls under the umbrella issue of Cytotoxic T cell, Multiple sclerosis, Downregulation and upregulation and Glatiramer acetate is strongly linked to Immunophenotyping.
His most cited work include:
- Changes in thymic function with age and during the treatment of HIV infection (1699 citations)
- HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells (1572 citations)
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial (1399 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Immunology, Virology, Antibody, Immune system and T cell.
His studies link Cytotoxic T cell with Immunology.
His Cytotoxic T cell research includes themes of Molecular biology, Cellular differentiation and Cell biology.
His biological study spans a wide range of topics, including Epitope, Antigen and DNA vaccination.
The study incorporates disciplines such as Flow cytometry and Viral replication in addition to T cell.
In Virus, Richard A. Koup works on issues like Acquired immunodeficiency syndrome, which are connected to Viral disease.
He most often published in these fields:
- Immunology (69.50%)
- Virology (58.16%)
- Antibody (25.53%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunology (69.50%)
- Virology (58.16%)
- Antibody (25.53%)
In recent papers he was focusing on the following fields of study:
Richard A. Koup mainly investigates Immunology, Virology, Antibody, Immune system and Vaccination.
His work is dedicated to discovering how Immunology, Cytotoxic T cell are connected with Effector and other disciplines.
His Virology study incorporates themes from Immunization and Antibody-dependent cell-mediated cytotoxicity.
His work investigates the relationship between Antibody and topics such as Potency that intersect with problems in In vivo.
Specifically, his work in Immune system is concerned with the study of T cell.
His Vaccination research integrates issues from HIV vaccine, Reactogenicity and Internal medicine, Lymph node.
Between 2015 and 2021, his most popular works were:
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses (189 citations)
- Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques (146 citations)
- Early antibody therapy can induce long-lasting immunity to SHIV (138 citations)
In his most recent research, the most cited papers focused on:
Richard A. Koup mostly deals with Immunology, Virology, Antibody, Virus and Clinical trial.
His Acquired immune system, Immunity, Vaccine efficacy, Lymphatic system and Germinal center investigations are all subjects of Immunology research.
His study in Virology is interdisciplinary in nature, drawing from both Epitope and Immunization.
His research is interdisciplinary, bridging the disciplines of CD8 and Antibody.
His Virus research incorporates elements of RNA, Chronic infection, DNA and Phylogenetic tree.
As a part of the same scientific study, he usually deals with the Clinical trial, concentrating on Immune system and frequently concerns with Proportional hazards model, Peripheral blood mononuclear cell, Clinical endpoint and HIV vaccine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
